Market closedNon-fractional

Verastem/VSTM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Verastem

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Ticker

VSTM

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Needham, United States

Employees

73

Verastem Metrics

BasicAdvanced
$69M
Market cap
-
P/E ratio
-$4.29
EPS
0.58
Beta
-
Dividend rate
$69M
0.58
4.403
4.133
109.459
113.552
-22.40%
-51.55%
-210.18%
2.8
2.8
-0.713
-3.03%
10.34%

What the Analysts think about Verastem

Analyst Ratings

Majority rating from 8 analysts.
Buy

Verastem Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$34M
23.81%
Profit margin
0.00%
NaN%

Verastem Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 26.42%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$1.37
-$0.75
-$1.02
-$1.26
-
Expected
-$1.06
-$0.84
-$0.62
-$1.00
-$0.98
Surprise
29.25%
-11.02%
64.52%
26.42%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Verastem stock?

Verastem (VSTM) has a market cap of $69M as of July 06, 2024.

What is the P/E ratio for Verastem stock?

The price to earnings (P/E) ratio for Verastem (VSTM) stock is 0 as of July 06, 2024.

Does Verastem stock pay dividends?

No, Verastem (VSTM) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Verastem dividend payment date?

Verastem (VSTM) stock does not pay dividends to its shareholders.

What is the beta indicator for Verastem?

Verastem (VSTM) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Verastem stock

Buy or sell Verastem stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing